Skip to content
AASLD Family of Websites: Liver Fellow Network
AASLD.org AASLD Foundation LiverLearning Career Center Journals The Liver Meeting HCV Guidelines
AASLD Logo
AASLD Logo

LFN Main Navigation

  • Topics
    Acute Liver Failure Alcohol-Associated Liver Disease Autoimmune Hepatitis Career Development and Mentorship Cholestatic Liver Disease Complications of Liver Disease and Portal Hypertension Drug-Induced Liver Disease HepMadness Inherited Disorders Liver Anatomy, Development, and Physiology Liver Infections Liver Physiology Liver Related Infections MASLD/MASH Neoplasms of the Liver Pathology Pediatrics Pregnancy-Related Liver Disease Symptoms and Clinical Presentation of Liver Disease and Portal HTN Systemic Conditions with Hepatic Manifestations Transplantation and Surgery Vascular Viral Hepatitis
  • Core Series
    Back to Basics Clinical Pearls Webinars Evidence Corner Pathology Pearls Liver Talks Podcasts The Why? Series Tools of the Trade View All Core Series Guidelines Practice Questions
  • Tweetorials
  • About
  • Core Series
  • Evidence Corner
  • Transplant Oncology

Transplant Oncology

October 14, 2025

Rakshana Ravichandran

Share

Copy Link Twitter Facebook
  • Cost-effectiveness analysis of interventional liver-directed therapies for downstaging of HCC before liver transplant
  • Role of protein induced by vitamin-K absence-II in transplanted patients with HCC not producing alpha-fetoprotein
  • Recipient hepatectomy technique may affect oncological outcomes of liver transplantation for hepatocellular carcinoma
HepMadness

Share

Copy Link Twitter Facebook

Written By:

Rakshana Ravichandran

IM Resident, Trinity Health Oakland/Wayne State School of Medicine

Related Content

Thyroid-Liver Axis

October 14, 2025

Rise of Artificial Intelligence in Hepatology

October 14, 2025

The Rise of Radiation for HCC

October 14, 2025

AASLD LFN Logo

Follow Us

Disclaimer & Privacy Policy

© 2025 American Association for the Study of Liver Diseases